Login / Signup

Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel.

Kim A PappJennifer BeeckerCurtis L CooperMark G KirchhofAnton L PozniakJuergen K RockstrohJan P DutzMelinda J GooderhamRobert GniadeckiH Chih-Ho HongCharles W LyndeCatherine MaariYves PoulinRonald B VenderSharon L Walmsley
Published in: Dermatology and therapy (2022)
Drug-related benefits and risks when treating a patient with systemic psoriasis therapies are similar for non-HIV patients and PLHIV with a suppressed viral load and normalized CD4 counts. Prior to initiating psoriasis treatment in PLHIV, HIV replication should be addressed by an HIV specialist. Exercise additional caution for patients with a suppressed viral load and discordant CD4 responses on antiretroviral therapy.
Keyphrases